| pubmed-article:15780420 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15780420 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:15780420 | lifeskim:mentions | umls-concept:C0023343 | lld:lifeskim |
| pubmed-article:15780420 | lifeskim:mentions | umls-concept:C0443286 | lld:lifeskim |
| pubmed-article:15780420 | lifeskim:mentions | umls-concept:C1444748 | lld:lifeskim |
| pubmed-article:15780420 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:15780420 | pubmed:dateCreated | 2005-3-22 | lld:pubmed |
| pubmed-article:15780420 | pubmed:abstractText | Type 1 (reversal or upgrading) reactions occur during or after chemotherapy in around 10% leprosy patients [Int J Lepr Other Mycobact Dis 61 (1993) 8-15]. The cause of this immunological upgrading is incompletely defined, although the approximately 2-fold increased risk of reaction in patients vaccinated with Mycobacterium w suggests that infection by mycobacteria other than Mycobacterium leprae may trigger this phenomenon [Vaccine 13 (1995) 1102-1110]. We report a case of borderline lepromatous leprosy in which we studied the antigenic specificity of peripheral blood mononuclear cells immediately before, and then during, a Type 1 reaction which provides more direct evidence in favor of this hypothesis. | lld:pubmed |
| pubmed-article:15780420 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15780420 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15780420 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15780420 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15780420 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15780420 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:15780420 | pubmed:issn | 0163-4453 | lld:pubmed |
| pubmed-article:15780420 | pubmed:author | pubmed-author:WilkinsonRobe... | lld:pubmed |
| pubmed-article:15780420 | pubmed:author | pubmed-author:LockwoodDiana... | lld:pubmed |
| pubmed-article:15780420 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15780420 | pubmed:volume | 50 | lld:pubmed |
| pubmed-article:15780420 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15780420 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15780420 | pubmed:pagination | 242-3 | lld:pubmed |
| pubmed-article:15780420 | pubmed:meshHeading | pubmed-meshheading:15780420... | lld:pubmed |
| pubmed-article:15780420 | pubmed:meshHeading | pubmed-meshheading:15780420... | lld:pubmed |
| pubmed-article:15780420 | pubmed:meshHeading | pubmed-meshheading:15780420... | lld:pubmed |
| pubmed-article:15780420 | pubmed:meshHeading | pubmed-meshheading:15780420... | lld:pubmed |
| pubmed-article:15780420 | pubmed:meshHeading | pubmed-meshheading:15780420... | lld:pubmed |
| pubmed-article:15780420 | pubmed:meshHeading | pubmed-meshheading:15780420... | lld:pubmed |
| pubmed-article:15780420 | pubmed:meshHeading | pubmed-meshheading:15780420... | lld:pubmed |
| pubmed-article:15780420 | pubmed:meshHeading | pubmed-meshheading:15780420... | lld:pubmed |
| pubmed-article:15780420 | pubmed:meshHeading | pubmed-meshheading:15780420... | lld:pubmed |
| pubmed-article:15780420 | pubmed:meshHeading | pubmed-meshheading:15780420... | lld:pubmed |
| pubmed-article:15780420 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15780420 | pubmed:articleTitle | Antigenic trigger for type 1 reaction in leprosy. | lld:pubmed |
| pubmed-article:15780420 | pubmed:affiliation | Division of Medicine, Wellcome Trust Centre for Research Clinical Tropical Medicine, Imperial College London, 2nd Floor Wright Fleming Institute, Norfolk Place, London W2 1PG, UK. r.j.wilkinson@imperial.ac.uk | lld:pubmed |
| pubmed-article:15780420 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15780420 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15780420 | lld:pubmed |
